世界中の市場調査レポートを販売!当社に無いレポートもお探しします。

レポートナンバー 0000030411

バイオプロセスコンテナ市場-2026年までの世界予測

MarketsandMarkets

Bioprocess Containers Market - Global Forecast to 2026

発刊日 2021/09

言語英語

体裁PDF/216ページ

ライセンス/価格216ページ

0000030411

Single
5-user
Corporate
Global

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※本レポートは、英文です。PDF(電子媒体)での納品となります。
※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。

無料サンプル

  • サンプルはお問い合わせください。

レポート概要

バイオプロセスコンテナ市場:種類別(2Dおよび3Dバッグ、装備品)、用途別(プロセス開発、上流および下流プロセス)、エンドユーザー別(医薬品&バイオ医薬品企業、CMO&CRO、学術、研究所)、地域別- 2026年までの世界予測

世界のバイオプロセスコンテナ(BPC)市場は、2021年の29億ドルから、2026年までに96億ドルに拡大し、予測期間中のCAGRは26.3%と予想されます。バイオプロセスコンテナ市場の成長を促す主な要因としては、成長を続ける生物製剤市場、使い捨てバイオプロセス技術の手頃な価格と持続可能性、バイオ医薬品の研究開発の増加が挙げられます。予測期間中は、新興国と生物製剤の特許満了が、バイオプロセスコンテナ市場のプレーヤーに成長機会をもたらすでしょう。

COVID-19がバイオプロセスコンテナ市場に与える影響

WHOがウイルスの発生をパンデミックとして公式に宣言したことで、大手製薬会社とバイオプロセスコンテナ市場のプレーヤーが一体となって新型コロナウイルス感染症を標的とした治療薬やワクチンの開発に乗り出しました。

主要なCOVID-19ワクチンプログラムのほとんどは、mRNA、DNAワクチン、ベクターなどの新しいアプローチを用いているため、これらのプラットフォームは主にシングルユース技術に基づいて構築されています。パンデミック関連の新しい施設のほとんどは、従来のステンレス鋼設備と比較して柔軟性と高速性、および初期コストが非常に安価であることから、使い捨てシステムに連動しています。

したがって、COVID-19パンデミック関連の研究のための使い捨て技術の採用の増加は、主要プレーヤーによるワクチン開発の増加と相まって、バイオプロセスコンテナ市場にプラスの影響を与えると予想されます。

レポート詳細

目次

TABLE OF CONTENTS

1 INTRODUCTION (Page No. - 32)
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
FIGURE 1 BIOPROCESS CONTAINERS MARKET SEGMENTATION
1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 LIMITATIONS
1.6 STAKEHOLDERS
1.7 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY (Page No. - 36)
2.1 RESEARCH DESIGN
FIGURE 2 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.1.1 Secondary sources: Bioprocess containers market
2.1.2 PRIMARY DATA
FIGURE 3 BREAKDOWN OF PRIMARIES: BIOPROCESS CONTAINERS MARKET
2.1.2.1 Key data from primary sources
2.2 MARKET SIZE ESTIMATION
FIGURE 4 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
2.2.1 REVENUE MAPPING-BASED MARKET ESTIMATION
FIGURE 5 MARKET SIZE ESTIMATION: BIOPROCESS CONTAINERS MARKET
2.2.2 PRIMARY RESEARCH VALIDATION
FIGURE 6 BIOPROCESS CONTAINERS MARKET: CAGR PROJECTIONS
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
FIGURE 7 DATA TRIANGULATION METHODOLOGY
2.4 ASSUMPTIONS FOR THE STUDY

3 EXECUTIVE SUMMARY (Page No. - 45)
FIGURE 8 BIOPROCESS CONTAINERS MARKET, BY TYPE, 2021 VS. 2026 (USD MILLION)
FIGURE 9 BIOPROCESS CONTAINERS MARKET, BY APPLICATION, 2021 VS. 2026 (USD MILLION)
FIGURE 10 BIOPROCESS CONTAINERS MARKET SHARE, BY END USER, 2020
FIGURE 11 GEOGRAPHICAL SNAPSHOT OF THE BIOPROCESS CONTAINERS MARKET

4 PREMIUM INSIGHTS (Page No. - 49)
4.1 BIOPROCESS CONTAINERS MARKET OVERVIEW
FIGURE 12 GROWING BIOLOGICS MARKET TO DRIVE MARKET GROWTH
4.2 ASIA PACIFIC: BIOPROCESS CONTAINERS MARKET, BY TYPE & COUNTRY (2020)
FIGURE 13 2D BIOPROCESS CONTAINERS ACCOUNTED FOR THE LARGEST SHARE OF THE APAC MARKET IN 2020
4.3 BIOPROCESS CONTAINERS MARKET, BY END USER
FIGURE 14 CMOS & CROS SEGMENT TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD

5 MARKET OVERVIEW (Page No. - 52)
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 15 BIOPROCESS CONTAINERS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 DRIVERS
5.2.1.1 Growing biologics market
FIGURE 16 GLOBAL BIOLOGICS MARKET, 2014─2023 (USD BILLION)
5.2.1.2 Affordability and sustainability of single-use bioprocess technologies
FIGURE 17 ADOPTION OF SINGLE-USE PRODUCTS IN BIOPHARMACEUTICAL MANUFACTURING, 2019
5.2.1.3 Rising biopharmaceutical R&D
FIGURE 18 GLOBAL R&D INVESTMENTS BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2010−2025 (USD BILLION)
5.2.2 RESTRAINTS
5.2.2.1 Issues related to leachables and extractables
TABLE 1 TYPICAL EXTRACTABLES FOR ACCEPTABLE MATERIALS USED IN DISPOSABLE BIOPROCESS MANUFACTURING SYSTEMS
5.2.3 OPPORTUNITIES
5.2.3.1 Emerging countries
5.2.3.2 Patent expiry of biologics
TABLE 2 US: BIOLOGICS GOING OFF-PATENT DURING 2018-2025
5.2.4 CHALLENGES
5.2.4.1 Waste disposal
TABLE 3 COMPARISON OF DISPOSAL OPTIONS FOR SINGLE-USE ASSEMBLY PRODUCTS
5.3 IMPACT OF COVID-19 ON THE BIOPROCESS CONTAINERS MARKET
FIGURE 19 COVID-19 IMPACT ON THE BIOPROCESS CONTAINERS MARKET, 2019─2021, (USD MILLION)

6 BIOPROCESS CONTAINERS MARKET, BY TYPE (Page No. - 61)
6.1 INTRODUCTION
TABLE 4 BIOPROCESS CONTAINERS MARKET, BY TYPE, 2017-2020 (USD MILLION)
TABLE 5 BIOPROCESS CONTAINERS MARKET, BY TYPE, 2021-2026 (USD MILLION)
6.2 2D BIOPROCESS CONTAINERS
6.2.1 WIDE USE OF 2D BAGS IN BIOPRODUCTION APPLICATIONS TO DRIVE MARKET GROWTH
TABLE 6 EXAMPLES OF 2D BIOPROCESS CONTAINERS AVAILABLE IN THE MARKET
TABLE 7 2D BIOPROCESS CONTAINERS MARKET, BY REGION, 2017-2020 (USD MILLION)
TABLE 8 2D BIOPROCESS CONTAINERS MARKET, BY REGION, 2021-2026 (USD MILLION)
TABLE 9 NORTH AMERICA: 2D BIOPROCESS CONTAINERS MARKET, BY COUNTRY, 2017-2020 (USD MILLION)
TABLE 10 NORTH AMERICA: 2D BIOPROCESS CONTAINERS MARKET, BY COUNTRY, 2021-2026 (USD MILLION)
TABLE 11 EUROPE: 2D BIOPROCESS CONTAINERS MARKET, BY COUNTRY, 2017-2020 (USD MILLION)
TABLE 12 EUROPE: 2D BIOPROCESS CONTAINERS MARKET, BY COUNTRY, 2021-2026 (USD MILLION)
TABLE 13 ASIA PACIFIC: 2D BIOPROCESS CONTAINERS MARKET, BY COUNTRY, 2017-2020 (USD MILLION)
TABLE 14 ASIA PACIFIC: 2D BIOPROCESS CONTAINERS MARKET, BY COUNTRY, 2021-2026 (USD MILLION)
6.3 3D BIOPROCESS CONTAINERS
6.3.1 SIGNIFICANT REDUCTIONS IN LABOR COSTS AND FASTER BATCH TURNAROUND ACHIEVED USING THESE CONTAINERS TO PROPEL MARKET GROWTH
TABLE 15 EXAMPLES OF 3D BIOPROCESS CONTAINERS AVAILABLE IN THE MARKET
TABLE 16 3D BIOPROCESS CONTAINERS MARKET, BY REGION, 2017-2020 (USD MILLION)
TABLE 17 3D BIOPROCESS CONTAINERS MARKET, BY REGION, 2021-2026 (USD MILLION)
TABLE 18 NORTH AMERICA: 3D BIOPROCESS CONTAINERS MARKET, BY COUNTRY, 2017-2020 (USD MILLION)
TABLE 19 NORTH AMERICA: 3D BIOPROCESS CONTAINERS MARKET, BY COUNTRY, 2021-2026 (USD MILLION)
TABLE 20 EUROPE: 3D BIOPROCESS CONTAINERS MARKET, BY COUNTRY, 2017-2020 (USD MILLION)
TABLE 21 EUROPE: 3D BIOPROCESS CONTAINERS MARKET, BY COUNTRY, 2021-2026 (USD MILLION)
TABLE 22 ASIA PACIFIC: 3D BIOPROCESS CONTAINERS MARKET, BY COUNTRY, 2017-2020 (USD MILLION)
TABLE 23 ASIA PACIFIC: 3D BIOPROCESS CONTAINERS MARKET, BY COUNTRY, 2021-2026 (USD MILLION)
6.4 OTHER CONTAINERS & ACCESSORIES
TABLE 24 OTHER BIOPROCESS CONTAINERS & ACCESSORIES MARKET, BY REGION, 2017-2020 (USD MILLION)
TABLE 25 OTHER BIOPROCESS CONTAINERS & ACCESSORIES MARKET, BY REGION, 2021-2026 (USD MILLION)
TABLE 26 NORTH AMERICA: OTHER BIOPROCESS CONTAINERS & ACCESSORIES MARKET, BY COUNTRY, 2017-2020 (USD MILLION)
TABLE 27 NORTH AMERICA: OTHER BIOPROCESS CONTAINERS & ACCESSORIES MARKET, BY COUNTRY, 2021-2026 (USD MILLION)
TABLE 28 EUROPE: OTHER BIOPROCESS CONTAINERS & ACCESSORIES MARKET, BY COUNTRY, 2017-2020 (USD MILLION)
TABLE 29 EUROPE: OTHER BIOPROCESS CONTAINERS & ACCESSORIES MARKET, BY COUNTRY, 2021-2026 (USD MILLION)
TABLE 30 ASIA PACIFIC: OTHER BIOPROCESS CONTAINERS & ACCESSORIES MARKET, BY COUNTRY, 2017-2020 (USD MILLION)
TABLE 31 ASIA PACIFIC: OTHER BIOPROCESS CONTAINERS & ACCESSORIES MARKET, BY COUNTRY, 2021-2026 (USD MILLION)

7 BIOPROCESS CONTAINERS MARKET, BY APPLICATION (Page No. - 75)
7.1 INTRODUCTION
TABLE 32 BIOPROCESS CONTAINERS MARKET, BY APPLICATION, 2017-2020 (USD MILLION)
TABLE 33 BIOPROCESS CONTAINERS MARKET, BY APPLICATION, 2021-2026 (USD MILLION)
7.2 UPSTREAM PROCESSES
7.2.1 FREQUENT USE OF BIOPROCESS CONTAINERS DURING FERMENTATION AND CULTURE MEDIA PROCESSING IS A MAJOR FACTOR DRIVING THE MARKET
TABLE 34 BIOPROCESS CONTAINERS MARKET FOR UPSTREAM PROCESSES, BY REGION, 2017-2020 (USD MILLION)
TABLE 35 BIOPROCESS CONTAINERS MARKET FOR UPSTREAM PROCESSES, BY REGION, 2021-2026 (USD MILLION)
TABLE 36 NORTH AMERICA: BIOPROCESS CONTAINERS MARKET FOR UPSTREAM PROCESSES, BY COUNTRY, 2017-2020 (USD MILLION)
TABLE 37 NORTH AMERICA: BIOPROCESS CONTAINERS MARKET FOR UPSTREAM PROCESSES, BY COUNTRY, 2021-2026 (USD MILLION)
TABLE 38 EUROPE: BIOPROCESS CONTAINERS MARKET FOR UPSTREAM PROCESSES, BY COUNTRY, 2017-2020 (USD MILLION)
TABLE 39 EUROPE: BIOPROCESS CONTAINERS MARKET FOR UPSTREAM PROCESSES, BY COUNTRY, 2021-2026 (USD MILLION)
TABLE 40 ASIA PACIFIC: BIOPROCESS CONTAINERS MARKET FOR UPSTREAM PROCESSES, BY COUNTRY, 2017-2020 (USD MILLION)
TABLE 41 ASIA PACIFIC: BIOPROCESS CONTAINERS MARKET FOR UPSTREAM PROCESSES, BY COUNTRY, 2021-2026 (USD MILLION)
7.3 DOWNSTREAM PROCESSES
7.3.1 WIDE USAGE OF BPC ASSEMBLY FOR PURIFICATION APPLICATIONS TO DRIVE MARKET GROWTH
TABLE 42 BIOPROCESS CONTAINERS MARKET FOR DOWNSTREAM PROCESSES, BY REGION, 2017-2020 (USD MILLION)
TABLE 43 BIOPROCESS CONTAINERS MARKET FOR DOWNSTREAM PROCESSES, BY REGION, 2021-2026 (USD MILLION)
TABLE 44 NORTH AMERICA: BIOPROCESS CONTAINERS MARKET FOR DOWNSTREAM PROCESSES, BY COUNTRY, 2017-2020 (USD MILLION)
TABLE 45 NORTH AMERICA: BIOPROCESS CONTAINERS MARKET FOR DOWNSTREAM PROCESSES, BY COUNTRY, 2021-2026 (USD MILLION)
TABLE 46 EUROPE: BIOPROCESS CONTAINERS MARKET FOR DOWNSTREAM PROCESSES, BY COUNTRY, 2017-2020 (USD MILLION)
TABLE 47 EUROPE: BIOPROCESS CONTAINERS MARKET FOR DOWNSTREAM PROCESSES, BY COUNTRY, 2021-2026 (USD MILLION)
TABLE 48 ASIA PACIFIC: BIOPROCESS CONTAINERS MARKET FOR DOWNSTREAM PROCESSES, BY COUNTRY, 2017-2020 (USD MILLION)
TABLE 49 ASIA PACIFIC: BIOPROCESS CONTAINERS MARKET FOR DOWNSTREAM PROCESSES, BY COUNTRY, 2021-2026 (USD MILLION)
7.4 PROCESS DEVELOPMENT
7.4.1 REDUCED RISK OF CROSS-CONTAMINATION AND REDUCED OPERATIONAL COSTS MAKE BPCS THE MOST PREFERRED SOLUTION FOR PROCESS DEVELOPMENT
TABLE 50 BIOPROCESS CONTAINERS MARKET FOR PROCESS DEVELOPMENT, BY REGION, 2017-2020 (USD MILLION)
TABLE 51 BIOPROCESS CONTAINERS MARKET FOR PROCESS DEVELOPMENT, BY REGION, 2021-2026 (USD MILLION)
TABLE 52 NORTH AMERICA: BIOPROCESS CONTAINERS MARKET FOR PROCESS DEVELOPMENT, BY COUNTRY, 2017-2020 (USD MILLION)
TABLE 53 NORTH AMERICA: BIOPROCESS CONTAINERS MARKET FOR PROCESS DEVELOPMENT, BY COUNTRY, 2021-2026 (USD MILLION)
TABLE 54 EUROPE: BIOPROCESS CONTAINERS MARKET FOR PROCESS DEVELOPMENT, BY COUNTRY, 2017-2020 (USD MILLION)
TABLE 55 EUROPE: BIOPROCESS CONTAINERS MARKET FOR PROCESS DEVELOPMENT, BY COUNTRY, 2021-2026 (USD MILLION)
TABLE 56 ASIA PACIFIC: BIOPROCESS CONTAINERS MARKET FOR PROCESS DEVELOPMENT, BY COUNTRY, 2017-2020 (USD MILLION)
TABLE 57 ASIA PACIFIC: BIOPROCESS CONTAINERS MARKET FOR PROCESS DEVELOPMENT, BY COUNTRY, 2021-2026 (USD MILLION)

8 BIOPROCESS CONTAINERS MARKET, BY END USER (Page No. - 90)
8.1 INTRODUCTION
TABLE 58 BIOPROCESS CONTAINERS MARKET, BY END USER, 2017-2020 (USD MILLION)
TABLE 59 BIOPROCESS CONTAINERS MARKET, BY END USER, 2021-2026 (USD MILLION)
8.2 PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES
8.2.1 BPCS HAVE FOUND WIDE USE IN BIOPHARMACEUTICAL MANUFACTURING DUE TO THEIR COST-EFFECTIVENESS
TABLE 60 BIOPROCESS CONTAINERS MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY REGION, 2017-2020 (USD MILLION)
TABLE 61 BIOPROCESS CONTAINERS MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY REGION, 2021-2026 (USD MILLION)
TABLE 62 NORTH AMERICA: BIOPROCESS CONTAINERS MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2017-2020 (USD MILLION) 93
TABLE 63 NORTH AMERICA: BIOPROCESS CONTAINERS MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2021-2026 (USD MILLION) 93
TABLE 64 EUROPE: BIOPROCESS CONTAINERS MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2017-2020 (USD MILLION)
TABLE 65 EUROPE: BIOPROCESS CONTAINERS MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2021-2026 (USD MILLION)
TABLE 66 ASIA PACIFIC: BIOPROCESS CONTAINERS MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2017-2020 (USD MILLION) 95
TABLE 67 APAC: BIOPROCESS CONTAINERS MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2021-2026 (USD MILLION)
8.3 CONTRACT RESEARCH ORGANIZATIONS & CONTRACT MANUFACTURING ORGANIZATIONS
8.3.1 INCREASING OUTSOURCING OF R&D SERVICES BY PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES TO SUPPORT MARKET GROWTH
TABLE 68 BIOPROCESS CONTAINERS MARKET FOR CROS & CMOS, BY REGION, 2017-2020 (USD MILLION)
TABLE 69 BIOPROCESS CONTAINERS MARKET FOR CROS & CMOS, BY REGION, 2021-2026 (USD MILLION)
TABLE 70 NORTH AMERICA: BIOPROCESS CONTAINERS MARKET FOR CROS & CMOS, BY COUNTRY, 2017-2020 (USD MILLION)
TABLE 71 NORTH AMERICA: BIOPROCESS CONTAINERS MARKET FOR CROS & CMOS, BY COUNTRY, 2021-2026 (USD MILLION)
TABLE 72 EUROPE: BIOPROCESS CONTAINERS MARKET FOR CROS & CMOS, BY COUNTRY, 2017-2020 (USD MILLION)
TABLE 73 EUROPE: BIOPROCESS CONTAINERS MARKET FOR CROS & CMOS, BY COUNTRY, 2021-2026 (USD MILLION)
TABLE 74 ASIA PACIFIC: BIOPROCESS CONTAINERS MARKET FOR CROS & CMOS, BY COUNTRY, 2017-2020 (USD MILLION)
TABLE 75 ASIA PACIFIC: BIOPROCESS CONTAINERS MARKET FOR CROS & CMOS, BY COUNTRY, 2021-2026 (USD MILLION)
8.4 ACADEMIC & RESEARCH INSTITUTES
8.4.1 GROWING COLLABORATIONS BETWEEN PHARMACEUTICAL & BIOPHARMACEUTICAL MANUFACTURERS AND RESEARCH INSTITUTES TO DRIVE MARKET GROWTH
TABLE 76 BIOPROCESS CONTAINERS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2017-2020 (USD MILLION)
TABLE 77 BIOPROCESS CONTAINERS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2021-2026 (USD MILLION)
TABLE 78 NORTH AMERICA: BIOPROCESS CONTAINERS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2017-2020 (USD MILLION)
TABLE 79 NORTH AMERICA: BIOPROCESS CONTAINERS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021-2026 (USD MILLION)
TABLE 80 EUROPE: BIOPROCESS CONTAINERS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2017-2020 (USD MILLION)
TABLE 81 EUROPE: BIOPROCESS CONTAINERS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021-2026 (USD MILLION)
TABLE 82 ASIA PACIFIC: BIOPROCESS CONTAINERS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2017-2020 (USD MILLION)
TABLE 83 ASIA PACIFIC: BIOPROCESS CONTAINERS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021-2026 (USD MILLION)

9 BIOPROCESS CONTAINERS MARKET, BY REGION (Page No. - 104)
9.1 INTRODUCTION
TABLE 84 BIOPROCESS CONTAINERS MARKET, BY REGION, 2017-2020 (USD MILLION)
TABLE 85 BIOPROCESS CONTAINERS MARKET, BY REGION, 2021-2026 (USD MILLION)
9.2 NORTH AMERICA
FIGURE 20 NORTH AMERICA: BIOPROCESS CONTAINERS MARKET SNAPSHOT
TABLE 86 NORTH AMERICA: BIOPROCESS CONTAINERS MARKET, BY COUNTRY, 2017-2020 (USD MILLION)
TABLE 87 NORTH AMERICA: BIOPROCESS CONTAINERS MARKET, BY COUNTRY, 2021-2026 (USD MILLION)
TABLE 88 NORTH AMERICA: BIOPROCESS CONTAINERS MARKET, BY TYPE, 2017-2020 (USD MILLION)
TABLE 89 NORTH AMERICA: BIOPROCESS CONTAINERS MARKET, BY TYPE, 2021-2026 (USD MILLION)
TABLE 90 NORTH AMERICA: BIOPROCESS CONTAINERS MARKET, BY APPLICATION, 2017-2020 (USD MILLION)
TABLE 91 NORTH AMERICA: BIOPROCESS CONTAINERS MARKET, BY APPLICATION, 2021-2026 (USD MILLION)
TABLE 92 NORTH AMERICA: BIOPROCESS CONTAINERS MARKET, BY END USER, 2017-2020 (USD MILLION)
TABLE 93 NORTH AMERICA: BIOPROCESS CONTAINERS MARKET, BY END USER, 2021-2026 (USD MILLION)
9.2.1 US
9.2.1.1 The US dominates the North American bioprocess containers market
TABLE 94 US: BIOPROCESS CONTAINERS MARKET, BY TYPE, 2017-2020 (USD MILLION)
TABLE 95 US: BIOPROCESS CONTAINERS MARKET, BY TYPE, 2021-2026 (USD MILLION)
TABLE 96 US: BIOPROCESS CONTAINERS MARKET, BY APPLICATION, 2017-2020 (USD MILLION)
TABLE 97 US: BIOPROCESS CONTAINERS MARKET, BY APPLICATION, 2021-2026 (USD MILLION)
TABLE 98 US: BIOPROCESS CONTAINERS MARKET, BY END USER, 2017-2020 (USD MILLION)
TABLE 99 US: BIOPROCESS CONTAINERS MARKET, BY END USER, 2021-2026 (USD MILLION)
9.2.2 CANADA
9.2.2.1 Growing number of biopharmaceutical manufacturing facilities is supporting the growth of the market in Canada
FIGURE 21 CANADA: BIOLOGICS SALES, 2009-2018 (USD BILLION)
TABLE 100 CANADA: BIOPROCESS CONTAINERS MARKET, BY TYPE, 2017-2020 (USD MILLION)
TABLE 101 CANADA: BIOPROCESS CONTAINERS MARKET, BY TYPE, 2021-2026 (USD MILLION)
TABLE 102 CANADA: BIOPROCESS CONTAINERS MARKET, BY APPLICATION, 2017-2020 (USD MILLION)
TABLE 103 CANADA: BIOPROCESS CONTAINERS MARKET, BY APPLICATION, 2021-2026 (USD MILLION)
TABLE 104 CANADA: BIOPROCESS CONTAINERS MARKET, BY END USER, 2017-2020 (USD MILLION)
TABLE 105 CANADA: BIOPROCESS CONTAINERS MARKET, BY END USER, 2021-2026 (USD MILLION)
9.3 EUROPE
TABLE 106 EUROPE: BIOPROCESS CONTAINERS MARKET, BY COUNTRY, 2017-2020 (USD MILLION)
TABLE 107 EUROPE: BIOPROCESS CONTAINERS MARKET, BY COUNTRY, 2021-2026 (USD MILLION)
TABLE 108 EUROPE: BIOPROCESS CONTAINERS MARKET, BY TYPE, 2017-2020 (USD MILLION)
TABLE 109 EUROPE: BIOPROCESS CONTAINERS MARKET, BY TYPE, 2021-2026 (USD MILLION)
TABLE 110 EUROPE: BIOPROCESS CONTAINERS MARKET, BY APPLICATION, 2017-2020 (USD MILLION)
TABLE 111 EUROPE: BIOPROCESS CONTAINERS MARKET, BY APPLICATION, 2021-2026 (USD MILLION)
TABLE 112 EUROPE: BIOPROCESS CONTAINERS MARKET, BY END USER, 2017-2020 (USD MILLION)
TABLE 113 EUROPE: BIOPROCESS CONTAINERS MARKET, BY END USER, 2021-2026 (USD MILLION)
9.3.1 GERMANY
9.3.1.1 Increasing adoption of single-use bioprocess systems by biopharmaceutical and CDMO companies to drive market growth
TABLE 114 GERMANY: BIOPROCESS CONTAINERS MARKET, BY TYPE, 2017-2020 (USD MILLION)
TABLE 115 GERMANY: BIOPROCESS CONTAINERS MARKET, BY TYPE, 2021-2026 (USD MILLION)
TABLE 116 GERMANY: BIOPROCESS CONTAINERS MARKET, BY APPLICATION, 2017-2020 (USD MILLION)
TABLE 117 GERMANY: BIOPROCESS CONTAINERS MARKET, BY APPLICATION, 2021-2026 (USD MILLION)
TABLE 118 GERMANY: BIOPROCESS CONTAINERS MARKET, BY END USER, 2017-2020 (USD MILLION)
TABLE 119 GERMANY: BIOPROCESS CONTAINERS MARKET, BY END USER, 2021-2026 (USD MILLION)
9.3.2 UK
9.3.2.1 Rising government support for biotechnology companies to propel the demand for advanced technologies in the UK
TABLE 120 UK: BIOPROCESS CONTAINERS MARKET, BY TYPE, 2017-2020 (USD MILLION)
TABLE 121 UK: BIOPROCESS CONTAINERS MARKET, BY TYPE, 2021-2026 (USD MILLION)
TABLE 122 UK: BIOPROCESS CONTAINERS MARKET, BY APPLICATION, 2017-2020 (USD MILLION)
TABLE 123 UK: BIOPROCESS CONTAINERS MARKET, BY APPLICATION, 2021-2026 (USD MILLION)
TABLE 124 UK: BIOPROCESS CONTAINERS MARKET, BY END USER,2017-2020 (USD MILLION)
TABLE 125 UK: BIOPROCESS CONTAINERS MARKET, BY END USER, 2021-2026 (USD MILLION)
9.3.3 FRANCE
9.3.3.1 Increasing investments in life science R&D infrastructure development to support market growth
TABLE 126 FRANCE: BIOPROCESS CONTAINERS MARKET, BY TYPE, 2017-2020 (USD MILLION)
TABLE 127 FRANCE: BIOPROCESS CONTAINERS MARKET, BY TYPE, 2021-2026 (USD MILLION)
TABLE 128 FRANCE: BIOPROCESS CONTAINERS MARKET, BY APPLICATION, 2017-2020 (USD MILLION)
TABLE 129 FRANCE: BIOPROCESS CONTAINERS MARKET, BY APPLICATION, 2021-2026 (USD MILLION)
TABLE 130 FRANCE: BIOPROCESS CONTAINERS MARKET, BY END USER, 2017-2020 (USD MILLION)
TABLE 131 FRANCE: BIOPROCESS CONTAINERS MARKET, BY END USER, 2021-2026 (USD MILLION)
9.3.4 ITALY
9.3.4.1 High R&D investments in the field of biotechnology research to support market growth in Italy
TABLE 132 ITALY: BIOPROCESS CONTAINERS MARKET, BY TYPE, 2017-2020 (USD MILLION)
TABLE 133 ITALY: BIOPROCESS CONTAINERS MARKET, BY TYPE, 2021-2026 (USD MILLION)
TABLE 134 ITALY: BIOPROCESS CONTAINERS MARKET, BY APPLICATION, 2017-2020 (USD MILLION)
TABLE 135 ITALY: BIOPROCESS CONTAINERS MARKET, BY APPLICATION, 2021-2026 (USD MILLION)
TABLE 136 ITALY: BIOPROCESS CONTAINERS MARKET, BY END USER, 2017-2020 (USD MILLION)
TABLE 137 ITALY: BIOPROCESS CONTAINERS MARKET, BY END USER, 2021-2026 (USD MILLION)
9.3.5 ROE
TABLE 138 ROE: BIOPROCESS CONTAINERS MARKET, BY TYPE, 2017-2020 (USD MILLION)
TABLE 139 ROE: BIOPROCESS CONTAINERS MARKET, BY TYPE, 2021-2026 (USD MILLION)
TABLE 140 ROE: BIOPROCESS CONTAINERS MARKET, BY APPLICATION, 2017-2020 (USD MILLION)
TABLE 141 ROE: BIOPROCESS CONTAINERS MARKET, BY APPLICATION, 2021-2026 (USD MILLION)
TABLE 142 ROE: BIOPROCESS CONTAINERS MARKET, BY END USER, 2017-2020 (USD MILLION)
TABLE 143 ROE: BIOPROCESS CONTAINERS MARKET, BY END USER, 2021-2026 (USD MILLION)
9.4 ASIA PACIFIC
FIGURE 22 ASIA PACIFIC: BIOPROCESS CONTAINERS MARKET SNAPSHOT
TABLE 144 ASIA PACIFIC: BIOPROCESS CONTAINERS MARKET, BY COUNTRY, 2017-2020 (USD MILLION)
TABLE 145 ASIA PACIFIC: BIOPROCESS CONTAINERS MARKET, BY COUNTRY, 2021-2026 (USD MILLION)
TABLE 146 ASIA PACIFIC: BIOPROCESS CONTAINERS MARKET, BY TYPE, 2017-2020 (USD MILLION)
TABLE 147 ASIA PACIFIC: BIOPROCESS CONTAINERS MARKET, BY TYPE, 2021-2026 (USD MILLION)
TABLE 148 ASIA PACIFIC: BIOPROCESS CONTAINERS MARKET, BY APPLICATION, 2017-2020 (USD MILLION)
TABLE 149 ASIA PACIFIC: BIOPROCESS CONTAINERS MARKET, BY APPLICATION, 2021-2026 (USD MILLION)
TABLE 150 ASIA PACIFIC: BIOPROCESS CONTAINERS MARKET, BY END USER, 2017-2020 (USD MILLION)
TABLE 151 ASIA PACIFIC: BIOPROCESS CONTAINERS MARKET, BY END USER, 2021-2026 (USD MILLION)
9.4.1 CHINA
9.4.1.1 China to witness the highest growth in the global bioprocess containers market
TABLE 152 CHINA: BIOPROCESS CONTAINERS MARKET, BY TYPE, 2017-2020 (USD MILLION)
TABLE 153 CHINA: BIOPROCESS CONTAINERS MARKET, BY TYPE, 2021-2026 (USD MILLION)
TABLE 154 CHINA: BIOPROCESS CONTAINERS MARKET, BY APPLICATION, 2017-2020 (USD MILLION)
TABLE 155 CHINA: BIOPROCESS CONTAINERS MARKET, BY APPLICATION, 2021-2026 (USD MILLION)
TABLE 156 CHINA: BIOPROCESS CONTAINERS MARKET, BY END USER, 2017-2020 (USD MILLION)
TABLE 157 CHINA: BIOPROCESS CONTAINERS MARKET, BY END USER,2021-2026 (USD MILLION)
9.4.2 SOUTH KOREA
9.4.2.1 Government support to boost the production of biological to drive market growth
TABLE 158 SOUTH KOREA: BIOPROCESS CONTAINERS MARKET, BY TYPE, 2017-2020 (USD MILLION)
TABLE 159 SOUTH KOREA: BIOPROCESS CONTAINERS MARKET, BY TYPE, 2021-2026 (USD MILLION)
TABLE 160 SOUTH KOREA: BIOPROCESS CONTAINERS MARKET, BY APPLICATION, 2017-2020 (USD MILLION)
TABLE 161 SOUTH KOREA: BIOPROCESS CONTAINERS MARKET, BY APPLICATION, 2021-2026 (USD MILLION)
TABLE 162 SOUTH KOREA: BIOPROCESS CONTAINERS MARKET, BY END USER, 2017-2020 (USD MILLION)
TABLE 163 SOUTH KOREA: BIOPROCESS CONTAINERS MARKET, BY END USER, 2021-2026 (USD MILLION)
9.4.3 JAPAN
9.4.3.1 Expansion of biopharmaceutical manufacturing plants in Japan has created growth opportunities for BPC companies
TABLE 164 JAPAN: BIOPROCESS CONTAINERS MARKET, BY TYPE, 2017-2020 (USD MILLION)
TABLE 165 JAPAN: BIOPROCESS CONTAINERS MARKET, BY TYPE, 2021-2026 (USD MILLION)
TABLE 166 JAPAN: BIOPROCESS CONTAINERS MARKET, BY APPLICATION, 2017-2020 (USD MILLION)
TABLE 167 JAPAN: BIOPROCESS CONTAINERS MARKET, BY APPLICATION, 2021-2026 (USD MILLION)
TABLE 168 JAPAN: BIOPROCESS CONTAINERS MARKET, BY END USER, 2017-2020 (USD MILLION)
TABLE 169 JAPAN: BIOPROCESS CONTAINERS MARKET, BY END USER, 2021-2026 (USD MILLION)
9.4.4 INDIA
9.4.4.1 COVID-19 vaccines production has created significant demand for single-use bioprocess containers
TABLE 170 INDIA: BIOPROCESS CONTAINERS MARKET, BY TYPE, 2017-2020 (USD MILLION)
TABLE 171 INDIA: BIOPROCESS CONTAINERS MARKET, BY TYPE, 2021-2026 (USD MILLION)
TABLE 172 INDIA: BIOPROCESS CONTAINERS MARKET, BY APPLICATION,2017-2020 (USD MILLION)
TABLE 173 INDIA: BIOPROCESS CONTAINERS MARKET, BY APPLICATION, 2021-2026 (USD MILLION)
TABLE 174 INDIA: BIOPROCESS CONTAINERS MARKET, BY END USER, 2017-2020 (USD MILLION)
TABLE 175 INDIA: BIOPROCESS CONTAINERS MARKET, BY END USER, 2021-2026 (USD MILLION)
9.4.5 ROAPAC
TABLE 176 ROAPAC: BIOPROCESS CONTAINERS MARKET, BY TYPE, 2017-2020 (USD MILLION)
TABLE 177 ROAPAC: BIOPROCESS CONTAINERS MARKET, BY TYPE, 2021-2026 (USD MILLION)
TABLE 178 ROAPAC: BIOPROCESS CONTAINERS MARKET, BY APPLICATION, 2017-2020 (USD MILLION)
TABLE 179 ROAPAC: BIOPROCESS CONTAINERS MARKET, BY APPLICATION, 2021-2026 (USD MILLION)
TABLE 180 ROAPAC: BIOPROCESS CONTAINERS MARKET, BY END USER, 2017-2020 (USD MILLION)
TABLE 181 ROAPAC: BIOPROCESS CONTAINERS MARKET, BY END USER, 2021-2026 (USD MILLION)
9.5 REST OF THE WORLD
TABLE 182 ROW: BIOPROCESS CONTAINERS MARKET, BY TYPE, 2017-2020 (USD MILLION)
TABLE 183 ROW: BIOPROCESS CONTAINERS MARKET, BY TYPE, 2021-2026 (USD MILLION)
TABLE 184 ROW: BIOPROCESS CONTAINERS MARKET, BY APPLICATION, 2017-2020 (USD MILLION)
TABLE 185 ROW: BIOPROCESS CONTAINERS MARKET, BY APPLICATION,2021-2026 (USD MILLION)
TABLE 186 ROW: BIOPROCESS CONTAINERS MARKET, BY END USER, 2017-2020 (USD MILLION)
TABLE 187 ROW: BIOPROCESS CONTAINERS MARKET, BY END USER, 2021-2026 (USD MILLION)

10 COMPETITIVE LANDSCAPE (Page No. - 153)
10.1 INTRODUCTION
10.2 RIGHT-TO-WIN APPROACHES ADOPTED BY KEY PLAYERS
FIGURE 23 BIOPROCESS CONTAINERS MARKET: RIGHT-TO-WIN STRATEGIES ADOPTED BY KEY PLAYERS
10.3 MARKET SHARE ANALYSIS
FIGURE 24 BIOPROCESS CONTAINERS: MARKET SHARE ANALYSIS, 2020
10.4 COMPANY EVALUATION QUADRANT
FIGURE 25 BIOPROCESS CONTAINERS MARKET: COMPANY EVALUATION MATRIX, 2020
10.4.1 STARS
10.4.2 PERVASIVE PLAYERS
10.4.3 EMERGING LEADERS
10.4.4 PARTICIPANTS
10.5 COMPETITIVE SCENARIO
10.5.1 DEALS
TABLE 188 BIOPROCESS CONTAINERS MARKET: DEALS, JANUARY 2018-MAY 2021
10.5.2 OTHER DEVELOPMENTS

11 COMPANY PROFILES (Page No. - 160)
11.1 KEY COMPANIES
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
11.1.1 SARTORIUS STEDIM BIOTECH
TABLE 189 SARTORIUS STEDIM BIOTECH: BUSINESS OVERVIEW
FIGURE 26 SARTORIUS STEDIM BIOTECH: COMPANY SNAPSHOT (2020)
TABLE 190 SARTORIUS STEDIM BIOTECH: PRODUCT OFFERINGS
TABLE 191 SARTORIUS STEDIM BIOTECH: DEALS
TABLE 192 SARTORIUS STEDIM BIOTECH: OTHER DEVELOPMENTS
11.1.2 THERMO FISHER SCIENTIFIC INC.
TABLE 193 THERMO FISHER SCIENTIFIC INC.: BUSINESS OVERVIEW
FIGURE 27 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2020)
TABLE 194 THERMO FISHER SCIENTIFIC INC.: PRODUCT OFFERINGS
TABLE 195 THERMO FISHER SCIENTIFIC INC.: DEALS
TABLE 196 THERMO FISHER SCIENTIFIC INC.: OTHER DEVELOPMENTS
11.1.3 DANAHER CORPORATION
TABLE 197 DANAHER CORPORATION: BUSINESS OVERVIEW
FIGURE 28 DANAHER CORPORATION: COMPANY SNAPSHOT (2020)
TABLE 198 DANAHER CORPORATION: PRODUCT OFFERINGS
TABLE 199 DANAHER CORPORATION: DEALS
TABLE 200 DANAHER CORPORATION: OTHER DEVELOPMENTS
11.1.4 MERCK KGAA
TABLE 201 MERCK KGAA: BUSINESS OVERVIEW
FIGURE 29 MERCK KGAA: COMPANY SNAPSHOT (2020)
TABLE 202 MERCK KGAA: PRODUCT OFFERINGS
TABLE 203 MERCK KGAA: OTHER DEVELOPMENTS
11.1.5 SAINT-GOBAIN
TABLE 204 SAINT-GOBAIN: BUSINESS OVERVIEW
FIGURE 30 SAINT-GOBAIN: COMPANY SNAPSHOT (2020)
TABLE 205 SAINT-GOBAIN: PRODUCT OFFERINGS
TABLE 206 SAINT-GOBAIN: DEALS
TABLE 207 SAINT-GOBAIN: OTHER DEVELOPMENTS
11.1.6 AVANTOR, INC.
TABLE 208 AVANTOR, INC.: BUSINESS OVERVIEW
FIGURE 31 AVANTOR, INC.: COMPANY SNAPSHOT (2020)
TABLE 209 AVANTOR, INC.: PRODUCT OFFERINGS
TABLE 210 AVANTOR, INC.: DEALS
TABLE 211 AVANTOR, INC.: OTHER DEVELOPMENTS
11.1.7 PARKER HANNIFIN CORPORATION
TABLE 212 PARKER HANNIFIN CORPORATION: BUSINESS OVERVIEW
FIGURE 32 PARKER HANNIFIN CORPORATION: COMPANY SNAPSHOT (2020)
TABLE 213 PARKER HANNIFIN: PRODUCT OFFERINGS
TABLE 214 PARKER HANNIFIN: OTHER DEVELOPMENTS
11.1.8 CORNING INCORPORATED
TABLE 215 CORNING INCORPORATED: BUSINESS OVERVIEW
FIGURE 33 CORNING INCORPORATED: COMPANY SNAPSHOT (2020)
TABLE 216 CORNING INCORPORATED: PRODUCT OFFERINGS
11.1.9 ENTEGRIS, INC.
TABLE 217 ENTEGRIS, INC.: BUSINESS OVERVIEW
FIGURE 34 ENTEGRIS, INC.: COMPANY SNAPSHOT (2020)
TABLE 218 ENTEGRIS, INC.: PRODUCT OFFERINGS
TABLE 219 ENTEGRIS, INC.: DEALS
TABLE 220 ENTEGRIS, INC.: OTHER DEVELOPMENTS
11.1.10 MEISSNER FILTRATION PRODUCTS, INC.
TABLE 221 MEISSNER FILTRATION PRODUCTS, INC.: BUSINESS OVERVIEW
TABLE 222 MEISSNER FILTRATION PRODUCTS, INC.: PRODUCT OFFERINGS
11.1.11 LONZA AG
TABLE 223 LONZA AG: BUSINESS OVERVIEW
FIGURE 35 LONZA AG: COMPANY SNAPSHOT (2020)
TABLE 224 LONZA AG: PRODUCT OFFERINGS
11.1.12 ANTYLIA SCIENTIFIC
TABLE 225 ANTYLIA SCIENTIFIC: BUSINESS OVERVIEW
TABLE 226 ANTYLIA SCIENTIFIC: PRODUCT OFFERINGS
11.1.13 FLEXBIOSYS INC.
TABLE 227 FLEXBIOSYS INC.: BUSINESS OVERVIEW
TABLE 228 FLEXBIOSYS INC.: PRODUCT OFFERINGS
11.1.14 MICHELIN GROUP
TABLE 229 MICHELIN GROUP: BUSINESS OVERVIEW
TABLE 230 MICHELIN GROUP: PRODUCT OFFERINGS
TABLE 231 MICHELIN GROUP: PRODUCT APPROVALS
TABLE 232 MICHELIN GROUP: DEALS
11.1.15 ABEC, INC.
TABLE 233 ABEC, INC.: BUSINESS OVERVIEW
TABLE 234 ABEC, INC.: PRODUCT OFFERINGS
TABLE 235 ABEC, INC.: DEALS
TABLE 236 ABEC, INC.: OTHER DEVELOPMENTS
11.1.16 CELLEXUS
TABLE 237 CELLEXUS: BUSINESS OVERVIEW
TABLE 238 CELLEXUS: PRODUCT OFFERINGS
TABLE 239 CELLEXUS: DEALS
11.2 OTHER COMPANIES
11.2.1 KEOFITT A/S
TABLE 240 KEOFITT A/S: COMPANY OVERVIEW
11.2.2 FUJIMORI KOGYO CO., LTD.
TABLE 241 FUJIMORI KOGYO CO., LTD.: COMPANY OVERVIEW
11.2.3 CESCO BIOENGINEERING CO., LTD.
TABLE 242 CESCO BIOENGINEERING CO., LTD.: COMPANY OVERVIEW
11.2.4 SOLIDA BIOTECH GMBH
TABLE 243 SOLIDA BIOTECH GMBH: COMPANY OVERVIEW
11.2.5 SATAKE CHEMICAL EQUIPMENT MFG., LTD.
TABLE 244 SATAKE CHEMICAL EQUIPMENT MFG., LTD.: COMPANY OVERVIEW
11.2.6 STOBBE PHARMA GMBH
TABLE 245 STOBBE PHARMA GMBH: COMPANY OVERVIEW
11.2.7 CELLTAINER BIOTECH BV
TABLE 246 CELLTAINER BIOTECH BV: COMPANY OVERVIEW
11.2.8 FOXX LIFE SCIENCES
TABLE 247 FOXX LIFE SCIENCES: COMPANY OVERVIEW
11.2.9 SHANGHAI LEPURE BIOTECH CO., LTD.
TABLE 248 SHANGHAI LEPURE BIOTECH CO., LTD.: COMPANY OVERVIEW
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.

12 APPENDIX (Page No. - 210)
12.1 DISCUSSION GUIDE
12.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
12.3 AVAILABLE CUSTOMIZATIONS
12.4 RELATED REPORTS
12.5 AUTHOR DETAILS

この商品のレポートナンバー

0000030411

TOP